Global Glioblastoma Multiforme Treatment Market showed crucial growth in the recent years and is anticipated to witness a steep rise by generating an estimated revenue of US$ xx.xx million over the forecast period. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 10.98% during the forecast period, i.e. 2017-2025. Glioblastoma Multiforme is a type of tumor that starts developing from glial cells, which supports the health of nerve cells present inside the brain. GBM has become the most common type of brain tumor that can be either intratentorial (area located below tentorium cerebilli) or supratentorial (area located above the tentorium cerebilli). GBM primarily occurs in male that aged above 65 years.

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global glioblastoma mltiforme treatment market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global glioblastoma mltiforme treatment market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.    

Market Dynamics

The Glioblastoma Multiforme treatment market size is anticipated to grow over the forecast period, owing to the increase in number of GBM and brain tumor awareness programs and associations such as EndBrainCancer, GBM Heroes event. According to United Nations (UN) Organizations, in most low-income countries, the number of older persons is expected to triple by 2050. Rise in oncological incidences especially brain tumor, and increasing mortality rate due to brain tumor has generated the demand for effective treatment methods, which in-turn is expected to fuel the Glioblastoma Multiforme treatment market size. For instance, according to the National Brain Tumor Society, in 2018, 78,980 new cases of non-malignant, primary malignant and other central-nervous system tumors will be diagnosed in the United States. Increased research and clinical trials on treatment of GBM through immunotherapy, and gene therapy is expected to contribute in the growth of GBM treatment market. However, neurotoxicity caused by commercialized drug for GBM, coupled with lack of efficacy of GBM treatment which leads to increase in mortality rate may restrain the growth of global Glioblastoma Multiforme treatment market size.

Segment Analysis

Temozolomide, a chemotherapy drug is expected to hold the major revenue share in the global GBM treatment market over the forecast period, owing to the higher efficacy of drugs in the treatment of GBM and their lesser toxic nature. According to American Association for Cancer Research’s (AACR’s) journal Clinical Cancer Research, in pre-clinical studies Temozolomide showed its broad-spectrum anti-tumor activity towards a range of tumor types, it also demonstrated distribution to all tissues including penetration into the central nervous system.  The potential increase in drug’s efficacy when combined with radiotherapy and chemotherapy is expected to boost the growth of Temozolomide drug.

Regional Insight:

The global glioblastoma mltiforme treatment market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. North America is expected to hold the major market share in the global Glioblastoma multiforme treatment market, due to increased clinical research trials on GBM treatment in the region, coupled with increasing geriatric population in United States. Increased governmental and non-profit organization’s aid in escalating the number of clinical trials by providing fundings to the clinical research organizations is also anticipated to fuel the growth of GBM treatment market in North America. For instance, in 2015, government of Canada in partnership with the Brain Canada and the Canadian Cancer Society announced to provide an additional fund of US$ 5 million for brain cancer research.

Global Glioblastoma Multiforme Treatment Market Size, Share Analysis By Region 2017

In Europe, the glioblastoma multiforme treatment market share is witnessing growth due to the development in healthcare infrastructure, coupled with increased governmental support for the treatment of GBM. For instance, in May 2018 UK government announced that it will increase its investment in brain cancer research to US$ 67.82 million a year in honour of Dame Tessa Jowell, former cabinet minister of UK, who died of Glioblastoma multiforme brain tumor in May 2018. Latin America will projection measurable growth in coming years due to high aged population. Middle East and Africa held the largest share of the global market in 2018 and will expand at the highest CAGR during the forecast years. Asia Pacific will show significant growth over the forecast period due to

Global Glioblastoma Multiforme Treatment Market Study Objective

1. To forecast the market size of glioblastoma multiforme treatment market, along with describing and defining the market, in terms of volume and revenue as well as market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

2. Market analysis and forecast of glioblastoma multiforme treatment market on the basis of region, substrate and application or end-use industry. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

3. To analyze and elaborate significant factors that will have major impact on the growth of glioblastoma multiforme treatment market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of glioblastoma multiforme treatment market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the glioblastoma multiforme treatment market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

Key Players Landscape

Major players operating in Glioblastoma multiforme treatment market size include Sun Pharmaceutical Industries, Celldex Therapeutics, Inc., Pfizer Inc., F.Hoffmann La Roche, Bristol-Myers Squibb, Teva Pharmaceuticals, Exellixis Inc., AngioChem Inc., and Arbor Pharmaceuticals LLC. Major key players are focusing on registering novel drugs and treatment technologies for approval, in order to commercialize them and to provide patients with effective treatment options for brain tumor and GBM treatment. For instance, in July 2018, IsoRay Inc., received the clearance from the US Food and Drug Administration (FDA) for its GammaTile therapy, which is a brachytherapy technology for the treatment of recurrent brain tumors.

Global Glioblastoma Multiforme Treatment Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.